Study of ALTO-300 in MDD
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Adam Savitz, MD, PhD
Alto Neuroscience
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
45 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Site 189
Phoenix, Arizona, United States
Withdrawn - Site 200
Phoenix, Arizona, United States
Recruiting - Site 187
Yuma, Arizona, United States
Recruiting - Site 193
Rogers, Arkansas, United States
Recruiting - Site 218
Bellflower, California, United States
Recruiting - Site 217
Glendale, California, United States
Recruiting - Site 335
Lafayette, California, United States
Recruiting - Site 209
Los Angeles, California, United States
Recruiting - Site 219
Mather, California, United States
Recruiting - Site 194
Mission Viejo, California, United States
Recruiting - Site 197
Temecula, California, United States
Recruiting - Site 203
Colorado Springs, Colorado, United States
Recruiting - Site 349
Evergreen, Colorado, United States
Recruiting - Site 214
Norwalk, Connecticut, United States
Recruiting - Site 159
Clermont, Florida, United States
Recruiting - Site 225
Miami Gardens, Florida, United States
Recruiting - Site 190
Miami Lakes, Florida, United States
Recruiting - Site 161
Okeechobee, Florida, United States
Recruiting - Site 221
Tampa, Florida, United States
Recruiting - Site 220
West Palm Beach, Florida, United States
Recruiting - Site 224
Savannah, Georgia, United States
Recruiting - Site 208
Snellville, Georgia, United States
Recruiting - Site 119
Boise, Idaho, United States
Recruiting - Site 310
Chicago, Illinois, United States
Recruiting - Site 201
Marrero, Louisiana, United States
Terminated - Site 198
Monroe, Louisiana, United States
Terminated - Site 215
Jackson, Mississippi, United States
Recruiting - Site 344
Las Vegas, Nevada, United States
Recruiting - Site 114
Albuquerque, New Mexico, United States
Recruiting - Site 191
Rochester, New York, United States
Terminated - Site 192
Staten Island, New York, United States
Recruiting - Site 199
Hickory, North Carolina, United States
Recruiting - Site 202
Cincinnati, Ohio, United States
Recruiting - Site 195
Oklahoma City, Oklahoma, United States
Recruiting - Site 216
Allentown, Pennsylvania, United States
Recruiting - Site 350
Media, Pennsylvania, United States
Recruiting - Site 352
Moosic, Pennsylvania, United States
Recruiting - Site 102
Dallas, Texas, United States
Withdrawn - Site 148
Fort Worth, Texas, United States
Withdrawn - Site 347
Fort Worth, Texas, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Jun 2023
- Primary completion
- 31 Dec 2026
- Completion
- 31 Dec 2026
- Last update posted
- 24 Jul 2025
- Registered enrollment
- 321
- Registry id
- NCT05922878
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.